• SyntekaBio postponed payment for its capital increase to Dec. 4, 2026, from Nov. 17 following discussions with investors.
• The subscription date moved to Dec. 1 from Nov. 10; new shares are scheduled to list Dec. 18 instead of Nov. 30.
• The third-party allotment comprises 1,616,814 common shares priced at KRW 1,237 each, raising KRW 2 billion for working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SyntekaBio Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261106000242), on November 06, 2026, and is solely responsible for the information contained therein.